PhaseBio Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PhaseBio Pharmaceuticals generated cash of -$47,416,000, which is more than the previous year. Cash used in financing activities reached the amount of $63,773,000 last year. Net change in cash is therefore $13,678,000.
Cash Flow
| 2016 | -9.68M | 9.24M | 1K |
|---|---|---|---|
| 2017 | -8.25M | -216K | 18.16M |
| 2018 | -17.05M | -119K | 64.79M |
| 2019 | -39.59M | -960K | 53.52M |
| 2020 | -59.95M | -1.41M | 15.46M |
| 2021 | -47.41M | -2.67M | 63.77M |
PHAS Cash Flow Statement (2016 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 28.12M | 74.02M | 61.05M | 13.42M | 3.71M | 4.15M |
Operating activities | ||||||
Net income | -131.07K | -98.56M | -39.24M | -23.84M | -10.24M | -9.22M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 1.79M | 508K | 174K | 105K | 96K | 92K |
Stock-based compensation expense | 2.26M | 2.23M | 1.42M | 332K | 77K | 160K |
| Deferred income tax benefit | 2.26M | 2.23M | 1.42M | 332K | 77K | 160K |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | 0 | 1.23M | 0 | 0 | 0 | 0 |
Inventories | 0 | -31.65M | 0 | 0 | 0 | 0 |
Accounts payable | 9.01M | 974K | 802K | 1.33M | -213K | -344K |
Cash generated by operating activities | -47.41M | -59.95M | -39.59M | -17.05M | -8.25M | -9.68M |
Investing activities | ||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -1.59M |
Investments In Property Plant And Equipment | -2.67M | -1.41M | -960K | -119K | -216K | -94K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.67M | -1.41M | -960K | -119K | -216K | 9.24M |
Financing activities | ||||||
Common Stock Issued | 60.35M | 2.94M | 46.27M | 42.97M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -5.45M | -2.72M | 0 | 0 | 0 | 0 |
Cash used in financing activities | 63.77M | 15.46M | 53.52M | 64.79M | 18.16M | 1K |
Net Change In Cash | 13.67M | -45.90M | 12.97M | 47.62M | 9.69M | -438K |
Cash at end of period | 41.8M | 28.12M | 74.02M | 61.05M | 13.40M | 3.71M |
| Data source | Data source | Data source | Data source |